Arecor was a spin-out from Insense (qv) to commercialise technology developed by Insense for enabling biologics to maintain their integrity without the need for refrigeration – this both reduces cost and also helps deployment in developing countries where temperature monitored cold storage facilities are in short supply. The technology also assists in maintaining the integrity and function of proteins exposed to ionizing radiation as the means of sterilisation.
Arecor Ltd
Developer of enhanced medicines
Company information
Company:
Public
Fund:
AIM EIS Fund, Growth Capital VCT
Sector:
Medical
Status:
Current
Investment Date:
05/2021
You might also be interested in...
Highly accredited engineering consultancy providing high-impact work package solutions for critical military platforms
Provider of specialist services to the construction and FM markets
Integrated technologies and services business enabling the delivery of genomic medicine